Charles Schwab Investment Management Inc Codiak Bio Sciences, Inc. Transaction History

Charles Schwab Investment Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.24 - $6.96 $91,452 - $284,155	-40,827 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$15.58 - $22.88 $65,139 - $95,661	4,181 Added 11.41%	40,827 $667,000
Q2 2021 Aug 16, 2021	BUY	$11.72 - $26.81 $229,313 - $524,564	19,566 Added 114.56%	36,646 $680,000
Q1 2021 May 17, 2021	BUY	$13.49 - $31.53 $73,911 - $172,752	5,479 Added 47.23%	17,080 $258,000
Q4 2020 Feb 16, 2021	BUY	$7.9 - $32.3 $91,647 - $374,712	11,601 New	11,601 $375,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.